Tumor initiating cells in malignant gliomas: biology and implications for therapy.
about
Exciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaMesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesMagnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapyFenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell SpheroidsOvercoming therapeutic resistance in glioblastoma: the way forwardSmall G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.Invasive glioblastoma cells acquire stemness and increased Akt activation.Gliomagenesis and the use of neural stem cells in brain tumor treatmentGlioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T CellsmiR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinaseOncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitroDesign and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency.Brain cancer propagating cells: biology, genetics and targeted therapiesSitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.The brain tumor microenvironment.The brain tumor microenvironment.Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement.Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.Clinical trials of viral therapy for malignant gliomas.Glioblastoma-initiating cells: relationship with neural stem cells and the micro-environment.Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.miR-92b regulates glioma cells proliferation, migration, invasion, and apoptosis via PTEN/Akt signaling pathway.Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.Long non-coding RNA in glioma: signaling pathways.MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.The Role of Protein Kinase B Signaling Pathway in Anti-Cancer Effect of Rolipram on Glioblastoma Multiforme: An In Vitro Study.TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells.Convection-enhanced delivery of sulfasalazine prolongs survival in a glioma stem cell brain tumor model.TRIP6 regulates neural stem cell maintenance in the postnatal mammalian subventricular zone.
P2860
Q24632791-15C8ADE4-BA53-4F1D-BF67-26ED10175AA7Q26799013-99AE8A04-C59C-4F30-8E9E-2467A047A933Q27004205-C586FE81-ECEA-4925-87E7-49ECC60F7D7EQ28552301-07A760B7-7EC8-496A-A56E-EDBEBD5199CFQ29248396-30414A61-2143-4074-BB36-7BD8C3892617Q33566796-EBCF6250-2D8A-4D8D-A1EC-7D9861583531Q33648875-A25CFB9C-714F-4D23-8B6B-2480C5D797B2Q33918861-0E430A71-5AC8-4B51-9842-88946354E5BEQ34310698-D244A532-D50B-42B5-93D4-FE2847C5E76EQ35988225-FE42F822-D570-455A-BE1A-F3F25D20BC54Q36626774-1AB4C54B-C9DE-4B20-818F-8EEAE77C5F2CQ36792756-2DF8CFF6-75B7-4BD8-9747-2FF6E8DF82FCQ36861550-E9ADE129-9504-4086-9F19-123FCEE545A7Q37025429-F3C8E26D-9951-4A42-8532-028036599DF2Q37130170-9064F9D1-4590-4350-AB68-8E1E1B38CDA4Q37579565-989BEC21-4740-4914-9E14-7432BF49F332Q37622195-FECAEBD5-3B44-458A-834E-736D64E2511FQ37627436-CEDA7EDC-09F6-4E97-BEB2-3693C7830324Q37818222-3EFB52A3-DDF8-4ABD-9836-D6204D532F5BQ37858468-C4ED9A34-C387-4787-BD70-191E0C210935Q37858940-E59C50F3-9497-4BDC-86D4-6074612DD4A4Q37989468-DA6B6147-37EF-4BAA-B430-7E6DD1345D80Q38045441-AAEB59B3-7483-4C59-AFBE-AF2431E3462EQ38097867-8E60DD1A-2284-4B7B-B8FC-1B3F8A24BF4AQ38153777-64286DC0-68D9-40B2-855F-9B9AB47451C5Q38160735-63E6292C-4F9E-4A95-9F32-E805969BEAB4Q38232172-CFCA6484-25A5-49CC-80DB-749FC1B01995Q38712677-874284B5-0F5F-4755-8A07-C07C203B3A59Q38792823-62147CE2-54C9-4AE0-9A9A-AD56A710BF3CQ39049644-AEBFAF28-2405-4C41-89B5-D1B874D722E9Q39130527-B41F6219-49F8-4099-93CD-7FFC18B44655Q39528026-7FAD13E8-EC35-4F4B-9B72-34109C82ED19Q41083946-503EBC64-28E7-45B3-A5D6-E3118E00D1FCQ44033285-FED4F18E-F74F-413E-AEBE-341E064AE3B9Q47129492-7230BF18-748E-498B-A3CB-1977EE77A215Q47878357-57FA7E5D-C16C-46F6-834B-23B938DB23F8Q48648082-378CCECC-69E2-433D-B45F-5C94E61D1401
P2860
Tumor initiating cells in malignant gliomas: biology and implications for therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor initiating cells in malignant gliomas: biology and implications for therapy.
@en
Tumor initiating cells in malignant gliomas: biology and implications for therapy.
@nl
type
label
Tumor initiating cells in malignant gliomas: biology and implications for therapy.
@en
Tumor initiating cells in malignant gliomas: biology and implications for therapy.
@nl
prefLabel
Tumor initiating cells in malignant gliomas: biology and implications for therapy.
@en
Tumor initiating cells in malignant gliomas: biology and implications for therapy.
@nl
P2860
P1476
Tumor initiating cells in malignant gliomas: biology and implications for therapy.
@en
P2093
Costas G Hadjipanayis
P2860
P2888
P304
P356
10.1007/S00109-009-0440-9
P577
2009-02-03T00:00:00Z